SALIX PHARMACEUTICALS LTD Additional Paid in Capital
SALIX PHARMACEUTICALS LTD had Additional Paid in Capital of $595.06 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2015-03-02
- 2014-12-31: Additional Paid in Capital $595.06M.
- 2014-09-30: Additional Paid in Capital $585.76M; Additional Paid in Capital as first filed $585.70M.
- 2014-06-30: Additional Paid in Capital $702.63M; Additional Paid in Capital as first filed $703.59M.
- 2014-03-31: Additional Paid in Capital $681.80M; Additional Paid in Capital as first filed $681.95M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2014-12-31 | $595.06M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $585.76M 10-Q/A · filed 2015-03-02 | $585.70M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $702.63M 10-Q/A · filed 2015-03-02 | $703.59M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $681.80M 10-Q/A · filed 2015-03-02 | $681.95M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $667.43M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $657.92M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $647.37M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $636.04M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $631.36M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $621.47M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $610.01M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $600.79M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $685.32M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $649.59M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $642.36M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $630.53M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $624.89M 10-K · filed 2012-02-28 |